Badoux, X. C., Keating, M. J., Wang, X., O'Brien, S. M., Ferrajoli, A., Faderl, S., . . . Wierda, W. G. (2011). Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. American Society of Hematology.
Chicago ZitierstilBadoux, Xavier C., et al. Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy Is Highly Effective Treatment for Relapsed Patients With CLL. American Society of Hematology, 2011.
MLA ZitierstilBadoux, Xavier C., et al. Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy Is Highly Effective Treatment for Relapsed Patients With CLL. American Society of Hematology, 2011.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.